Molecular Cancer Research, ISSN 1541-7786, 07/2011, Volume 9, Issue 7, pp. 960 - 975
Journal Article
MOLECULAR CANCER RESEARCH, ISSN 1541-7786, 07/2011, Volume 9, Issue 7, pp. 960 - 975
Epidermal growth factor receptors (EGFR) contribute to colonic tumorigenesis in experimental models of colon cancer. We previously showed that EGFR was also...
REAL-TIME PCR | GROWTH-FACTOR RECEPTOR | LUNG-CANCER | ONCOLOGY | COLORECTAL-CANCER | TYROSINE KINASE | PROSTATE-CANCER | CELL-LINES | MICRORNA EXPRESSION | AZOXYMETHANE MODEL | TISSUE-SECTIONS | CELL BIOLOGY
REAL-TIME PCR | GROWTH-FACTOR RECEPTOR | LUNG-CANCER | ONCOLOGY | COLORECTAL-CANCER | TYROSINE KINASE | PROSTATE-CANCER | CELL-LINES | MICRORNA EXPRESSION | AZOXYMETHANE MODEL | TISSUE-SECTIONS | CELL BIOLOGY
Journal Article
Journal of Engineering for Gas Turbines and Power, ISSN 0742-4795, 01/2018, Volume 140, Issue 1, pp. 011501 - 011501-12
A gas turbine combustion process subjected to high levels of centrifugal acceleration has demonstrated the potential for increased flame speeds and shorter...
ENGINEERING, MECHANICAL
ENGINEERING, MECHANICAL
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9793, pp. 771 - 784
Summary Background As trials of 5 years of tamoxifen in early breast cancer mature, the relevance of hormone receptor measurements (and other patient...
Internal Medicine | MEDICINE, GENERAL & INTERNAL | POSTMENOPAUSAL | THERAPY | HIGH-RISK | DOXORUBICIN | RECURRENCE | PREMENOPAUSAL WOMEN | PROGESTERONE-RECEPTOR | ESTROGEN-RECEPTOR | CHEMOTHERAPY | IMMUNOHISTOCHEMISTRY | Receptors, Estrogen - metabolism | Neoplasm Recurrence, Local - prevention & control | Humans | Selective Estrogen Receptor Modulators - adverse effects | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Randomized Controlled Trials as Topic | Receptors, Progesterone - metabolism | Antineoplastic Agents, Hormonal - adverse effects | Selective Estrogen Receptor Modulators - therapeutic use | Breast Neoplasms - pathology | Neoplasms, Second Primary - chemically induced | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Breast Neoplasms - mortality | Female | Chemotherapy, Adjuvant | Tamoxifen - adverse effects | Patient outcomes | Breast cancer | Research | Diagnosis | Tamoxifen | Drug therapy | Health aspects | Chemotherapy | Compliance | Womens health | Mortality | Endocrine therapy | Data collection | Stratigraphy | Cancer therapies | Medical and Health Sciences | Medicin och hälsovetenskap
Internal Medicine | MEDICINE, GENERAL & INTERNAL | POSTMENOPAUSAL | THERAPY | HIGH-RISK | DOXORUBICIN | RECURRENCE | PREMENOPAUSAL WOMEN | PROGESTERONE-RECEPTOR | ESTROGEN-RECEPTOR | CHEMOTHERAPY | IMMUNOHISTOCHEMISTRY | Receptors, Estrogen - metabolism | Neoplasm Recurrence, Local - prevention & control | Humans | Selective Estrogen Receptor Modulators - adverse effects | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Randomized Controlled Trials as Topic | Receptors, Progesterone - metabolism | Antineoplastic Agents, Hormonal - adverse effects | Selective Estrogen Receptor Modulators - therapeutic use | Breast Neoplasms - pathology | Neoplasms, Second Primary - chemically induced | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Breast Neoplasms - mortality | Female | Chemotherapy, Adjuvant | Tamoxifen - adverse effects | Patient outcomes | Breast cancer | Research | Diagnosis | Tamoxifen | Drug therapy | Health aspects | Chemotherapy | Compliance | Womens health | Mortality | Endocrine therapy | Data collection | Stratigraphy | Cancer therapies | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2017, Volume 69, Issue 7, pp. 777 - 785
BACKGROUND: GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry...
registry | oral anticoagulation | atrial fibrillation | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | GUIDELINES | RISK | EUROPEAN-SOCIETY | ATRIAL-FIBRILLATION | ANTITHROMBOTIC TREATMENT | THERAPY | WARFARIN | ORAL ANTICOAGULANTS | Stroke - prevention & control | Prospective Studies | Cross-Sectional Studies | Antithrombins - therapeutic use | Humans | Middle Aged | Atrial Fibrillation - complications | Male | Dabigatran - therapeutic use | Stroke - etiology | Internationality | Fibrinolytic Agents - therapeutic use | Female | Registries | Aged | Hypertension | Heart failure | Cardiac arrhythmia | Anticoagulants | Stroke | Statistical analysis | Cardiovascular disease | Alcohol | Valves | Family medical history | Patients | Demographics | Onsite | Quality | Data collection | Trends | Clinical medicine | Diabetes | Age
registry | oral anticoagulation | atrial fibrillation | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | GUIDELINES | RISK | EUROPEAN-SOCIETY | ATRIAL-FIBRILLATION | ANTITHROMBOTIC TREATMENT | THERAPY | WARFARIN | ORAL ANTICOAGULANTS | Stroke - prevention & control | Prospective Studies | Cross-Sectional Studies | Antithrombins - therapeutic use | Humans | Middle Aged | Atrial Fibrillation - complications | Male | Dabigatran - therapeutic use | Stroke - etiology | Internationality | Fibrinolytic Agents - therapeutic use | Female | Registries | Aged | Hypertension | Heart failure | Cardiac arrhythmia | Anticoagulants | Stroke | Statistical analysis | Cardiovascular disease | Alcohol | Valves | Family medical history | Patients | Demographics | Onsite | Quality | Data collection | Trends | Clinical medicine | Diabetes | Age
Journal Article
Science, ISSN 0036-8075, 2015, Volume 349, Issue 6251, pp. aac4716 - aac4716
Reproducibility is a defining feature of science, but the extent to which it characterizes current research is unknown. We conducted replications of 100...
REPLICATION | PUBLICATION | MULTIDISCIPLINARY SCIENCES | POWER | INCENTIVES | PREVALENCE | TRUTH | REPLICABILITY | Causality | Experimental psychology | Samhällsvetenskap | Social Sciences | Psychology | Psykologi
REPLICATION | PUBLICATION | MULTIDISCIPLINARY SCIENCES | POWER | INCENTIVES | PREVALENCE | TRUTH | REPLICABILITY | Causality | Experimental psychology | Samhällsvetenskap | Social Sciences | Psychology | Psykologi
Journal Article
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 01/2019, Volume 321, Issue 1, pp. 69 - 79
IMPORTANCE Type 2 diabetes is associated with increased cardiovascular (CV) risk. Prior trials have demonstrated CV safety of 3 dipeptidyl peptidase 4 (DPP-4)...
KIDNEY-DISEASE | MORTALITY | GFR DECLINE | END-POINT | SAXAGLIPTIN | HEART-FAILURE | SITAGLIPTIN | DEATH | OUTCOMES | CKD | MEDICINE, GENERAL & INTERNAL | Type 2 diabetes | Usage | Clinical trials | Research | Risk factors | Complications and side effects | Analysis | Placebos | Linagliptin | Dosage and administration | Kidney diseases | Cardiovascular diseases | Drug therapy | Myocardial infarction | End-stage renal disease | Adjudication | Risk | Effects | Incidence | Randomization | Vascular diseases | Safety engineering | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Peptidase | Epidermal growth factor receptors | Diabetes mellitus | Pancreatitis | Health risks | Hypoglycemia | Insulin | Patients | Placebo effect | Prescription drugs | Renal failure | Infarction | Adults | Diabetes | Online First | Original Investigation
KIDNEY-DISEASE | MORTALITY | GFR DECLINE | END-POINT | SAXAGLIPTIN | HEART-FAILURE | SITAGLIPTIN | DEATH | OUTCOMES | CKD | MEDICINE, GENERAL & INTERNAL | Type 2 diabetes | Usage | Clinical trials | Research | Risk factors | Complications and side effects | Analysis | Placebos | Linagliptin | Dosage and administration | Kidney diseases | Cardiovascular diseases | Drug therapy | Myocardial infarction | End-stage renal disease | Adjudication | Risk | Effects | Incidence | Randomization | Vascular diseases | Safety engineering | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Peptidase | Epidermal growth factor receptors | Diabetes mellitus | Pancreatitis | Health risks | Hypoglycemia | Insulin | Patients | Placebo effect | Prescription drugs | Renal failure | Infarction | Adults | Diabetes | Online First | Original Investigation
Journal Article